Information from Press Conferences and Official Media

Federal Information

(November 09, 2020)

Health Secretary

- The Undersecretary of Health, Dr. Lopez-Gatell, responded to the news of the preliminary advances of the Pfizer vaccine. He commented that it is encouraging news but that it should be taken with caution and moderation. He mentioned that a preliminary analysis is not enough, we need to see the He mentioned that a preliminary analysis is not enough, it is necessary to see the information reflected in a scientific publication that assures that the vaccine is of quality, safe and effective.

- He emphasized that there is no need to give in to political pressures in order to achieve a vaccine. The vaccine must pass the strictest strictest standards.

- When asked about the sanitary authorization on experimental drugs of antibodies against COVID-19, the Undersecretary commented that he did not have any information on the matter, but that, if the information was true, COFEPRIS would analyze it. that he had no information on the matter but that, if the information is true, COFEPRIS will be in charge of a thorough analysis of the drug. the drug in depth.

Secretaría de Relaciones Exteriores

- At the Morning Conference (Nov. 10), the Secretary of Foreign Affairs, Mr. Marcelo Ebrard, showed the progress being made with the COVID-19 vaccines. with the COVID-19 vaccines.

- Regarding the CanSino vaccine, the Secretary mentioned that Phase 3 of the clinical trial has already begun in the states of Guerrero and Oaxaca. He added that the clinical trial will soon begin in Aguascalientes, Mexico City, Coahuila, Michoacán and Nuevo León. He pointed out that between 12 and 15 thousand volunteers who meet the inclusion guidelines will participate in this clinical trial.

- On the progress of the Moderna vaccine, he reported that the cooperation with the pharmaceutical company continues to progress and that they are awaiting the results of Phase 3 clinical studies. results of the Phase 3 clinical studies.

- Finally, he commented that the possibility of conducting Phase 3 clinical trials of the Russian Sputnik V vaccine is being explored.

State Information

(November 09, 2020)

Health Secretary

- Dr. de la O, Secretary of State Health, called on authorities and citizens to monitor compliance with sanitary measures in order to reduce the number of daily infections. to reduce the number of daily infections.

- When asked about possible outbreaks of COVID-19 in government agencies, the Secretary dismissed such information.

- Regarding the exact numbers to know at what point the economic reactivation will be suspended or reversed, Dr. De la O mentioned that there is no exact number, since decisions are made based on the indicators that are presented. He pointed out that an important important indicator is the rate of hospitalizations.

- He again called on the Federation to send more PCR tests.

- He thanked the Governor of the State for his support, as he has prioritized health issues and has made a large investment in the sector.

Number of cases

Economic Situation

Financial indicators

Main economic news

(10 de Noviembre de 2020)

- Deputies will reallocate 2,407 million pesos from the PPEF; Secretaría del Bienestar, the most benefited. The largest decrease is for the Judicial Branch, with 1,130 million pesos, leaving its budget at $71,299 million pesos. million pesos, which would leave its budget at $71,299 million pesos (El Economista). Economist). https://bit.ly/36hnpVS

- T-MEC is not at risk even if Kamala Harris voted against it: Landau. The T-MEC is not 'Harry Potter', and it will not be able to avoid disputes, but it can make them more orderly and controlled, said Jesús Seade (El Financiero). https://bit.ly/35ifQPe

- EU to impose tariffs on US products for aid to Boeing. The World Trade World Trade Organization considered illegal a part of the U.S. support to Boeing, which is a rival to European Boeing, which is a rival of the European manufacturer Airbus (El Financiero). https://bit.ly/2JLSkls

World News

- Brazil suspends Chinese Covid-19 vaccine trials due to 'adverse effect'. Brazil's National Health Surveillance Agency (Anvisa) announced on Monday that it has temporarily that it determined the temporary suspension of clinical trials in the country of the vaccine against the vaccine against the coronavirus developed by the Chinese laboratory Sinovac, after being notified of the of the occurrence of a "serious adverse event". https://bit.ly/2UcAR7S

- EU emergency approval of experimental antibody drug against Eli Lilly's COVID-19. COVID-19 antibody drug from Eli Lilly. Eli Lilly's antibody drug received an emergency use authorization emergency use authorization from U.S. drug regulators to treat COVID-19, expanding the U.S. drug regulators to treat COVID-19, widening access to a treatment that early data suggests treatment that early data suggest is effective in keeping people infected with coronavirus infected with people infected with the coronavirus out of the hospital. https://bit.ly/3na4wec

- Australia begins production of AstraZeneca vaccine. The Australian Minister of Health Health Minister Greg Hunt announced on Monday that the Oceanic country has begun to produce the Cid-19 vaccine the vaccine against Cid-19 developed by the British pharmaceutical company AstraZeneca. https://bit.ly/3lkZ5ss